Literature DB >> 27777303

HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently.

An Li1, Jiawen Li1, Kenneth A Johnson2.   

Abstract

HIV reverse transcriptase plays a central role in viral replication and requires coordination of both polymerase and RNase H activities. Although this coordination is crucial in viral replication, whether a DNA/RNA hybrid can simultaneously engage both active sites has yet to be determined as structural and kinetic analyses have provided contradictory results. Single nucleotide incorporation and RNase H cleavage were examined using presteady-state kinetics with global data analysis. The results revealed three interconverting reverse transcriptase-DNA/RNA species; 43% were active for both sites simultaneously, 27% showed only polymerase activity, and the remaining 30% were nonproductive. Our data clearly demonstrated that the DNA/RNA hybrid could contact both active sites simultaneously, although the single nucleotide incorporation (105 s-1) was ∼5-fold faster than the cleavage (23 s-1). By using a series of primers with different lengths, we found that a string of at least 4-6 nucleotides downstream of the cleaving site was required for efficient RNA cleavage. This was corroborated by our observations that during processive nucleotide incorporation, sequential rounds of RNA cleavage occurred each time after ∼6 nucleotides were incorporated. More importantly, during processive primer extension, pyrophosphate (PPi) release was rate-limiting so that the average rate of nucleotide incorporation (∼28 s-1) was comparable with that of net RNA cleavage (∼27 nucleotides(s)). Although polymerization is efficient and processive, RNase H is inefficient and periodic. This combination allows the two catalytic centers of HIVRT to work simultaneously at similar speeds without being tightly coupled.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA polymerase; RNase H; cooperativity; enzyme kinetics; global data fitting; human immunodeficiency virus (HIV); reverse transcriptase; reverse transcription; transient kinetics

Mesh:

Substances:

Year:  2016        PMID: 27777303      PMCID: PMC5159515          DOI: 10.1074/jbc.M116.753160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription.

Authors:  Marcin Nowotny; Sergei A Gaidamakov; Rodolfo Ghirlando; Susana M Cerritelli; Robert J Crouch; Wei Yang
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

2.  Human immunodeficiency virus reverse transcriptase displays a partially processive 3' to 5' endonuclease activity.

Authors:  J J DeStefano; R G Buiser; L M Mallaber; R A Bambara; P J Fay
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

3.  A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active.

Authors:  D B Evans; K Brawn; M R Deibel; W G Tarpley; S K Sharma
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

4.  Role of induced fit in limiting discrimination against AZT by HIV reverse transcriptase.

Authors:  Matthew W Kellinger; Kenneth A Johnson
Journal:  Biochemistry       Date:  2011-05-13       Impact factor: 3.162

5.  How conformational dynamics of DNA polymerase select correct substrates: experiments and simulations.

Authors:  Serdal Kirmizialtin; Virginia Nguyen; Kenneth A Johnson; Ron Elber
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

6.  HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition.

Authors:  Greg L Beilhartz; Michaela Wendeler; Noel Baichoo; Jason Rausch; Stuart Le Grice; Matthias Götte
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

7.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

8.  Mechanism and fidelity of HIV reverse transcriptase.

Authors:  W M Kati; K A Johnson; L F Jerva; K S Anderson
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

9.  Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  S J Stahl; J D Kaufman; S Vikić-Topić; R J Crouch; P T Wingfield
Journal:  Protein Eng       Date:  1994-09

10.  HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors.

Authors:  Greg L Beilhartz; Matthias Götte
Journal:  Viruses       Date:  2010-03-30       Impact factor: 5.818

View more
  9 in total

1.  Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.

Authors:  Paul L Boyer; Steven J Smith; Xue Zhi Zhao; Kalyan Das; Kevin Gruber; Eddy Arnold; Terrence R Burke; Stephen H Hughes
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

2.  Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.

Authors:  Jennifer A Bohn; Justin DaSilva; Siarhei Kharytonchyk; Maria Mercedes; Jennifer Vosters; Alice Telesnitsky; Theodora Hatziioannou; Janet L Smith
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 3.  Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.

Authors:  Francesc Xavier Ruiz; Eddy Arnold
Journal:  Curr Opin Struct Biol       Date:  2020-01-11       Impact factor: 6.809

4.  Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity.

Authors:  An Li; Shanzhong Gong; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

5.  Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase.

Authors:  Małgorzata Figiel; Miroslav Krepl; Sangwoo Park; Jarosław Poznański; Krzysztof Skowronek; Agnieszka Gołąb; Taekjip Ha; Jiří Šponer; Marcin Nowotny
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

6.  Arm-specific cleavage and mutation during reverse transcription of 2΄,5΄-branched RNA by Moloney murine leukemia virus reverse transcriptase.

Authors:  Jessica Döring; Thomas Hurek
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

7.  Coordination between the polymerase and RNase H activity of HIV-1 reverse transcriptase.

Authors:  Malgorzata Figiel; Miroslav Krepl; Jaroslaw Poznanski; Agnieszka Golab; Jirí Šponer; Marcin Nowotny
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

8.  APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.

Authors:  Jennifer A Bohn; Keyur Thummar; Ashley York; Alice Raymond; W Clay Brown; Paul D Bieniasz; Theodora Hatziioannou; Janet L Smith
Journal:  Nat Commun       Date:  2017-10-18       Impact factor: 14.919

9.  Analysis and Molecular Determinants of HIV RNase H Cleavage Specificity at the PPT/U3 Junction.

Authors:  Mar Álvarez; Enrique Sapena-Ventura; Joanna Luczkowiak; Samara Martín-Alonso; Luis Menéndez-Arias
Journal:  Viruses       Date:  2021-01-18       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.